
1. malar j. 2019 nov 12;18(1):361. doi: 10.1186/s12936-019-2986-5.

a comprehensive analysis drug resistance molecular markers plasmodium
falciparum genetic diversity two malaria endemic sites mali.

diakité sas(1)(2), traoré k(3), sanogo i(3), clark tg(4), campino s(4), sangaré
m(3), dabitao d(3), dara a(3), konaté ds(3), doucouré f(3), cissé a(3), keita
b(3), doumbouya m(3), guindo ma(3), toure mb(3), sogoba n(3), doumbia s(3),
awandare ga(5), diakité m(3).

author information: 
(1)malaria research training center, university sciences, technics and
technologies bamako (usttb), bamako, mali. sdiakite@icermali.org.
(2)west african centre cell biology infectious pathogens, university of
ghana, accra, ghana. sdiakite@icermali.org.
(3)malaria research training center, university sciences, technics and
technologies bamako (usttb), bamako, mali.
(4)faculty infectious tropical diseases, london school hygiene and
tropical medicine, london, uk.
(5)west african centre cell biology infectious pathogens, university of
ghana, accra, ghana.

background: drug resistance one greatest challenges malaria control 
programme mali. recent advances next-generation sequencing (ngs)
technologies provide new effective ways tracking drug-resistant malaria
parasites africa. diversity prevalence plasmodium falciparum
drug-resistance molecular markers assessed dangassa nioro-du-sahel in
mali, two sites distinct malaria transmission patterns. dangassa an
intense seasonal malaria transmission, whereas nioro-du-sahel unstable and
short seasonal malaria transmission.
methods: 270 dried blood spot samples (214 dangassa 56 in
nioro-du-sahel) collected p. falciparum positive patients 2016.
samples analysed agena massarray® iplex platform. specific codons
were targeted pfcrt, pfmdr1, pfdhfr, pfdhps, pfarps10, pfferredoxin,
pfexonuclease pfmdr2 genes. sanger's 101-snps-barcode method used 
assess genetic diversity p. falciparum determine parasite
species.
results: pfcrt_76t chloroquine-resistance genotype found rate of
64.4% dangassa 45.2% nioro-du-sahel (p = 0.025). the
pfdhfr_51i-59r-108n pyrimethamine-resistance genotype 14.1% 19.6%,
respectively dangassa nioro-du-sahel. mutations the
pfdhps_s436-a437-k540-a581-613a sulfadoxine-resistance gene significantly
more prevalent dangassa compared nioro-du-sahel (p = 0.035). 17.8%
of isolates dangassa vs 7% nioro-du-sahel harboured least two
codon substitutions haplotype. amodiaquine-resistance pfmdr1_n86y
mutation identified three samples (two dangassa one in
nioro-du-sahel). lumefantrine-reduced susceptibility pfmdr1_y184f mutation
was found 39.9% 48.2% samples dangassa nioro-du-sahel,
respectively. one piperaquine-resistance exo_e415g mutation found in
dangassa, artemisinin resistance genetic-background identified. a
high p. falciparum diversity observed, clear genetic aggregation was
found either study sites. higher multiplicity infection observed in
dangassa coil (p = 0.04) real mccoil (p = 0.02) methods relative to
nioro-du-sahel.
conclusions: study reveals high prevalence chloroquine and
pyrimethamine-resistance markers well high codon substitution rate the
sulfadoxine-resistance gene. high genetic diversity p. falciparum was
observed. observations suggest use artemisinins relevant 
both dangassa nioro-du-sahel.

doi: 10.1186/s12936-019-2986-5 
pmcid: pmc6849310
pmid: 31718631  [indexed medline]

